| 6001 | KCTD5 levels | GCST90469670 | 1.00 |
| 6002 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T94 | ECGA000094 | 1.00 |
| 6003 | ISLR2 levels | GCST90469629 | 1.00 |
| 6004 | HEXIM1/NUB1 ratio | GCST90315049 | 0.99 |
| 6005 | BLVRB/HBQ1 ratio | GCST90313525 | 0.99 |
| 6006 | DTI TBSS FA Splenium of corpus callosum | GCST90384384 | 0.99 |
| 6007 | Non-cancer illness code, self-reported - high cholesterol | Medical conditions | UKBB00000516 | 0.99 |
| 6008 | Other non-epithelial cancer of skin (PheCode 172.2) | GCST90475580 | 0.99 |
| 6009 | ENG/PEAR1 ratio | GCST90314649 | 0.99 |
| 6010 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502160 | 0.99 |
| 6011 | Body fat percentage (adjusted for testosterone and SHBG) x sex interaction | GCST90432181 | 0.99 |
| 6012 | NRSN1 levels | GCST90242062 | 0.99 |
| 6013 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T326 | ECGU000326 | 0.99 |
| 6014 | LY96 levels | GCST90469823 | 0.99 |
| 6015 | Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2) | GCST90132957 | 0.98 |
| 6016 | HippSubfield lh volume Hippocampal-tail | GCST90002668 | 0.98 |
| 6017 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000811 | 0.98 |
| 6018 | Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302775 | 0.98 |
| 6019 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T66 | ECGA000066 | 0.98 |
| 6020 | PCDH17/TEK ratio | GCST90315606 | 0.98 |
| 6021 | QC tfMRI-to-T1 linear alignment discrepancy | GCST90006354 | 0.98 |
| 6022 | Type of accommodation lived in - A flat, maisonette or apartment | Household | UKBB00000868 | 0.98 |
| 6023 | ITPR1 levels | GCST90469655 | 0.98 |
| 6024 | IDP dMRI ProbtrackX L2 slf r | GCST90004295 | 0.98 |
| 6025 | CASP1 levels | GCST90468543 | 0.98 |
| 6026 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T32 | ECGU000032 | 0.98 |
| 6027 | Duration to complete alphanumeric path task (baseline) | GCST90565839 | 0.98 |
| 6028 | T1 FreeSurfer pial rh pericalcarine area | GCST90385842 | 0.98 |
| 6029 | FABP2/LGALS4 ratio | GCST90314756 | 0.98 |
| 6030 | Asthma, unspecified (mode) | FING00000120 | 0.98 |
| 6031 | SERPINB6 levels | GCST90470591 | 0.98 |
| 6032 | FSTL3 levels | GCST90425765 | 0.98 |
| 6033 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33) | GCST90320596 | 0.98 |
| 6034 | Lymphoid neoplasms | GCST90624743 | 0.98 |
| 6035 | IDP dMRI ProbtrackX ICVF cgc r | GCST90004380 | 0.97 |
| 6036 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428 | ECGU000428 | 0.97 |
| 6037 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320891 | 0.97 |
| 6038 | IDP dMRI ProbtrackX L3 str l | GCST90004323 | 0.97 |
| 6039 | SNX9/STIP1 ratio | GCST90315864 | 0.97 |
| 6040 | eosinophil (fraction, maximum, inv-norm transformed) | GCST90475297 | 0.97 |
| 6041 | X-21285 levels | GCST90200576 | 0.97 |
| 6042 | COCH levels | GCST90468810 | 0.97 |
| 6043 | MICB_MICA/TEK ratio | GCST90315446 | 0.97 |
| 6044 | Whiskey liking | GCST90094873 | 0.97 |
| 6045 | CLMP/TGFBR2 ratio | GCST90314135 | 0.97 |
| 6046 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402) | GCST90269499 | 0.97 |
| 6047 | 1-stearoyl-GPE (18:0) levels | GCST90199772 | 0.97 |
| 6048 | Intelligence | GCST90179114 | 0.97 |
| 6049 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 0.97 |
| 6050 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475354 | 0.97 |
| 6051 | MAN2B2 levels | GCST90469844 | 0.97 |
| 6052 | BACH1/CD2AP ratio | GCST90313435 | 0.97 |
| 6053 | wg lh intensity-contrast superiortemporal | GCST90003821 | 0.97 |
| 6054 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T342 | ECGA000342 | 0.97 |
| 6055 | FOXO1/USP8 ratio | GCST90314879 | 0.96 |
| 6056 | Beans liking | GCST90094699 | 0.96 |
| 6057 | IDP dMRI ProbtrackX L2 ilf r | GCST90004288 | 0.96 |
| 6058 | aparc-pial rh area parsopercularis | GCST90003191 | 0.96 |
| 6059 | IDP dMRI TBSS MD Cingulum hippocampus L | GCST90004064 | 0.96 |
| 6060 | CALCOCO1/MAP3K5 ratio | GCST90313605 | 0.96 |
| 6061 | aparc-a2009s rh volume S-front-inf | GCST90003050 | 0.96 |
| 6062 | rfMRI connectivity ICA-features 4 | GCST90006342 | 0.96 |
| 6063 | Deforming dorsopathies | FING00000385 | 0.96 |
| 6064 | FSTL3/LTBR ratio | GCST90314883 | 0.96 |
| 6065 | aparc-DKTatlas rh area fusiform | GCST90003270 | 0.96 |
| 6066 | PHOSPHO1 levels | GCST90470227 | 0.96 |
| 6067 | APP/CCL28 ratio | GCST90313317 | 0.96 |
| 6068 | FKBP4 levels | GCST90469243 | 0.95 |
| 6069 | DSG4/FABP9 ratio | GCST90314562 | 0.95 |
| 6070 | Lung cancer | GCST004748 | 0.95 |
| 6071 | Intervertebral disc disorders (PheCode 722) | GCST90476237 | 0.95 |
| 6072 | IDP dMRI ProbtrackX FA atr r | GCST90003928 | 0.95 |
| 6073 | C1R levels | GCST90468493 | 0.95 |
| 6074 | BA-exvivo lh thickness BA4p | GCST90003518 | 0.95 |
| 6075 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T302 | ECGU000302 | 0.95 |
| 6076 | Lymphoid neoplasms (P-cell phenocluster) | GCST90624737 | 0.95 |
| 6077 | Reaction time | GCST006268 | 0.95 |
| 6078 | High light scatter reticulocyte count (UKB data field 30300) | GCST90468076 | 0.95 |
| 6079 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354 | ECGA000354 | 0.95 |
| 6080 | wg lh intensity-contrast inferiortemporal | GCST90003800 | 0.95 |
| 6081 | Cholesterol in small LDL (UKB data field 23547) | GCST90269644 | 0.95 |
| 6082 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 0.95 |
| 6083 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T311 | ECGA000311 | 0.95 |
| 6084 | Falls/tendency to fall | FING00000530 | 0.95 |
| 6085 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000443 | 0.95 |
| 6086 | Percentage of M9 (GP18) | GCST90668696 | 0.95 |
| 6087 | Triacylglycerol_56:7_[M+NH4]1+ levels | GCST90060551 | 0.95 |
| 6088 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T409 | ECGA000409 | 0.95 |
| 6089 | PRKAB1 levels | GCST90470324 | 0.94 |
| 6090 | USP8 levels | GCST90471022 | 0.94 |
| 6091 | PTPRN2/RTBDN ratio | GCST90315754 | 0.94 |
| 6092 | IDP dMRI ProbtrackX L2 cst r | GCST90004282 | 0.94 |
| 6093 | Restless legs syndrome | GCST90435387 | 0.94 |
| 6094 | TNFSF8 levels | GCST90470923 | 0.94 |
| 6095 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279 | ECGU000279 | 0.94 |
| 6096 | Irregular menstrual cycle/bleeding | genitourinary | UKBB00000379 | 0.94 |
| 6097 | CPPED1 levels | GCST90468845 | 0.94 |
| 6098 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T136 | ECGU000136 | 0.94 |
| 6099 | CD79B/FCRL2 ratio | GCST90313900 | 0.94 |
| 6100 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226 | ECGU000226 | 0.94 |
| 6101 | SPTLC1 levels | GCST90427130 | 0.94 |
| 6102 | PTPN6 levels | GCST90470377 | 0.94 |
| 6103 | FST levels | GCST90012080 | 0.94 |
| 6104 | Pregnenediol sulfate (C21H34O5S) levels | GCST90199861 | 0.94 |
| 6105 | IDP dMRI TBSS L3 Cingulum hippocampus R | GCST90004207 | 0.94 |
| 6106 | IDP dMRI TBSS L1 Superior corona radiata R | GCST90004099 | 0.94 |
| 6107 | Basal cell carcinoma (PheCode 172.21) | GCST90475582 | 0.94 |
| 6108 | Lymphoid neoplasms (drug group 1 phenocluster) | GCST90624740 | 0.94 |
| 6109 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule L | GCST90004144 | 0.94 |
| 6110 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 0.94 |
| 6111 | ThalamNuclei lh volume Whole-thalamus | GCST90002762 | 0.94 |
| 6112 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T33 | ECGU000033 | 0.93 |
| 6113 | PRDX3 levels | GCST90470317 | 0.93 |
| 6114 | Right molecular layer hippocampal volume (body) | GCST90267975 | 0.93 |
| 6115 | CKAP4/PGF ratio | GCST90314075 | 0.93 |
| 6116 | Diseases of white blood cells (PheCode 288) | GCST90475812 | 0.93 |
| 6117 | Tea consumption | GCST90096926 | 0.93 |
| 6118 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T315 | ECGA000315 | 0.93 |
| 6119 | General happiness with own health | Happiness and subjective well-being | UKBB00000281 | 0.93 |
| 6120 | FOXO1/MAP4K5 ratio | GCST90314872 | 0.93 |
| 6121 | CREG1/GUSB ratio | GCST90314249 | 0.93 |
| 6122 | ECG, load | ECG during exercise | UKBB00000205 | 0.93 |
| 6123 | Pulse pressure (BMI adjusted) | GCST90335167 | 0.93 |
| 6124 | Thyroid peroxidase antibody levels in pregnancy | GCST90435201 | 0.93 |
| 6125 | Other peripheral nerve disorders (PheCode 351) | GCST90475842 | 0.93 |
| 6126 | total cholesterol (maximum, inv-norm transformed) | GCST90476418 | 0.93 |
| 6127 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T362 | ECGU000362 | 0.92 |
| 6128 | Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels | GCST90060148 | 0.92 |
| 6129 | CXCL10 levels | GCST90468923 | 0.92 |
| 6130 | FCRL6/GZMA ratio | GCST90314806 | 0.92 |
| 6131 | Functional digestive disorders | digestive | UKBB00000274 | 0.92 |
| 6132 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225 | ECGU000225 | 0.92 |
| 6133 | Gestational [pregnancy-induced] hypertension | FING00000571 | 0.92 |
| 6134 | SH3GLB2 levels | GCST90470621 | 0.92 |
| 6135 | DTI autoptx MD ptr l tract | GCST90385239 | 0.92 |
| 6136 | Alanine aminotransferase levels | GCST90018723 | 0.92 |
| 6137 | REG1A/REG4 ratio | GCST90315762 | 0.92 |
| 6138 | DTI TBSS MD Cingulum hippocampus R | GCST90384608 | 0.92 |
| 6139 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T295 | ECGA000295 | 0.92 |
| 6140 | wg lh intensity-contrast superiorfrontal | GCST90003819 | 0.92 |
| 6141 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | GCST90200041 | 0.92 |
| 6142 | Hyphaema and other vascular disorders of iris and ciliary body | FING00000647 | 0.91 |
| 6143 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280 | ECGU000280 | 0.91 |
| 6144 | SULT2A1 levels | GCST90470782 | 0.91 |
| 6145 | Cancer of urinary organs (incl. kidney and bladder) (PheCode 189) | GCST90475593 | 0.91 |
| 6146 | Noninfectious gastroenteritis | digestive | UKBB00000526 | 0.91 |
| 6147 | Ever had period extreme irritability | Mania | UKBB00000217 | 0.91 |
| 6148 | DTI TBSS MD Cingulum hippocampus L | GCST90384609 | 0.91 |
| 6149 | Wegener granulomatosis | FING00001446 | 0.91 |
| 6150 | Soft tissue disorders | FING00001316 | 0.91 |
| 6151 | Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance use | UKBB00000460 | 0.91 |
| 6152 | Blood cell traits latent factor 23 (white cell) | GCST90559265 | 0.91 |
| 6153 | CA4/TGFBR2 ratio | GCST90313588 | 0.91 |
| 6154 | Current tobacco smoking | Smoking | UKBB00000161 | 0.91 |
| 6155 | CRYGD levels | GCST90468876 | 0.91 |
| 6156 | IDP dMRI TBSS L3 Superior cerebellar peduncle R | GCST90004183 | 0.91 |
| 6157 | Hypothyroidism NOS | endocrine/metabolic | UKBB00000336 | 0.90 |
| 6158 | Asthma (childhood onset) | GCST007800 | 0.90 |
| 6159 | High cholesterol | GCST90475205 | 0.90 |
| 6160 | ICD10 E28.2: Polycystic ovarian syndrome | GCST90454205 | 0.90 |
| 6161 | Right ventricular stroke volume | GCST90134590 | 0.90 |
| 6162 | CDH1 levels | GCST90468670 | 0.90 |
| 6163 | Provencibacterium massiliense abundance in stool | GCST90032527 | 0.90 |
| 6164 | wg lh intensity-contrast posteriorcingulate | GCST90003814 | 0.90 |
| 6165 | BA-exvivo rh volume BA1 | GCST90002849 | 0.90 |
| 6166 | DTI autoptx L2 ifo l tract | GCST90385178 | 0.90 |
| 6167 | High light scatter reticulocyte count | GCST90002385 | 0.90 |
| 6168 | Selective deficiency of immunoglobulin G [IgG] subclasses | FING00001288 | 0.90 |
| 6169 | DLL1/NBL1 ratio | GCST90314496 | 0.90 |
| 6170 | Rheumatoid arthritis and other inflammatory (PheCode 714) | GCST90476228 | 0.90 |
| 6171 | Medication use (antithrombotic agents) | GCST90018762 | 0.89 |
| 6172 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T400 | ECGA000400 | 0.89 |
| 6173 | EPHB6 levels | GCST90469133 | 0.89 |
| 6174 | Other hypothyroidism | Disorders of thyroid gland | UKBB00000611 | 0.89 |
| 6175 | IDP dMRI TBSS L3 Superior longitudinal fasciculus L | GCST90004212 | 0.89 |
| 6176 | ROBO1/SPON1 ratio | GCST90315783 | 0.89 |
| 6177 | HPCAL1 levels | GCST90469471 | 0.89 |
| 6178 | SCT levels | GCST90470557 | 0.89 |
| 6179 | CPXM1/SPARC ratio | GCST90314222 | 0.89 |
| 6180 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 0.89 |
| 6181 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T405 | ECGA000405 | 0.89 |
| 6182 | IDP dMRI TBSS ICVF Body of corpus callosum | GCST90004330 | 0.89 |
| 6183 | FOLH1 levels | GCST90427192 | 0.89 |
| 6184 | Cholesterol to total lipids in small VLDL percentage (UKB data field 23600) | GCST90269697 | 0.89 |
| 6185 | DTI TBSS L2 Medial lemniscus L | GCST90384485 | 0.89 |
| 6186 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T316 | ECGA000316 | 0.89 |
| 6187 | IST1 levels | GCST90469632 | 0.89 |
| 6188 | Other specified/unspecified inflammatory spondylopathies | FING00001109 | 0.89 |
| 6189 | Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensive | UKBB00000660 | 0.89 |
| 6190 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 0.88 |
| 6191 | FEN1 levels | GCST90469213 | 0.88 |
| 6192 | DTI autoptx L3 ifo l tract | GCST90385205 | 0.88 |
| 6193 | EGFR/MEGF9 ratio | GCST90314614 | 0.88 |
| 6194 | AHSG levels | GCST90468263 | 0.88 |
| 6195 | ANXA4/HSPB1 ratio | GCST90313292 | 0.88 |
| 6196 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T406 | ECGA000406 | 0.88 |
| 6197 | CRACR2A/DNMBP ratio | GCST90314226 | 0.88 |
| 6198 | HippSubfield lh volume hippocampal-fissure | GCST90002672 | 0.88 |
| 6199 | Functional dyspepsia | FING00000561 | 0.88 |
| 6200 | Drusen (degenerative) of retina (PheCode 362.27) | GCST90475855 | 0.88 |
| 6201 | T1 FreeSurfer BA lh V1 exvivo area | GCST90385514 | 0.88 |
| 6202 | KLK8 levels | GCST90469707 | 0.88 |
| 6203 | DNAJB1 levels | GCST90469012 | 0.88 |
| 6204 | CLEC4D/HGF ratio | GCST90314110 | 0.88 |
| 6205 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491 | ECGU000491 | 0.88 |
| 6206 | IL1R2 levels | GCST90469572 | 0.88 |
| 6207 | NTN1 levels | GCST90242047 | 0.87 |
| 6208 | APOB levels | UKBB00000041 | 0.87 |
| 6209 | Haddock liking | GCST90094776 | 0.87 |
| 6210 | Diacylglycerol_34:0_[M+H-H2O]1+ levels | GCST90060181 | 0.87 |
| 6211 | BA-exvivo rh volume BA4a | GCST90002853 | 0.87 |
| 6212 | ERBIN/LYN ratio | GCST90314694 | 0.87 |
| 6213 | Alcohol use disorder, ICD-based | FING00000052 | 0.87 |
| 6214 | RRM2B levels | GCST90470500 | 0.87 |
| 6215 | IDP dMRI TBSS ICVF External capsule L | GCST90004360 | 0.87 |
| 6216 | ThalamNuclei rh volume CM | GCST90002742 | 0.87 |
| 6217 | PTGES2 levels | GCST90470369 | 0.87 |
| 6218 | Breast cancer | GCST90018579 | 0.87 |
| 6219 | Total cholesterol levels in medium VLDL | GCST90132689 | 0.87 |
| 6220 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T401 | ECGA000401 | 0.87 |
| 6221 | Carotid artery plaque burden | GCST90503076 | 0.87 |
| 6222 | aparc-a2009s rh volume S-parieto-occipital | GCST90003063 | 0.87 |
| 6223 | Coronary angioplasty | FING00000357 | 0.87 |
| 6224 | Saturated fatty acids levels | GCST90499950 | 0.87 |
| 6225 | EGLN1/PIK3AP1 ratio | GCST90314619 | 0.86 |
| 6226 | MITD1 levels | GCST90469910 | 0.86 |
| 6227 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T294 | ECGA000294 | 0.86 |
| 6228 | PDGFB/TNFSF13 ratio | GCST90315632 | 0.86 |
| 6229 | RND3 levels | GCST90422230 | 0.86 |
| 6230 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T310 | ECGU000310 | 0.86 |
| 6231 | CD40LG/SERPINE1 ratio | GCST90313826 | 0.86 |
| 6232 | Pulmonary fibrosis | GCST90018688 | 0.86 |
| 6233 | TJAP1 levels | GCST90470874 | 0.86 |
| 6234 | Skin elastin (cheek, R5) | GCST90502787 | 0.86 |
| 6235 | DSG3/NECTIN4 ratio | GCST90314560 | 0.86 |
| 6236 | FABP5 levels | GCST90469177 | 0.86 |
| 6237 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502397 | 0.86 |
| 6238 | Chronic obstructive pulmonary disease in non-current smokers | GCST90016594 | 0.86 |
| 6239 | Emotionally unstable personality disorder | FING00000495 | 0.86 |
| 6240 | PDCD1/TNFRSF9 ratio | GCST90315611 | 0.86 |
| 6241 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114 | ECGU000114 | 0.86 |
| 6242 | T1 CAT WM unnormalised volume | GCST90383983 | 0.86 |
| 6243 | ITGB1BP2 levels | GCST90469642 | 0.86 |
| 6244 | Atrial fibrillation | GCST90624412 | 0.85 |
| 6245 | Basal cell carcinoma (MTAG) | GCST90137411 | 0.85 |
| 6246 | LIPF levels | GCST90469780 | 0.85 |
| 6247 | Treatment/medication code - levothyroxine sodium | Medications | UKBB00000849 | 0.85 |
| 6248 | IDP dMRI TBSS ISOVF Corticospinal tract R | GCST90004483 | 0.85 |
| 6249 | EIF4E levels | GCST90469096 | 0.85 |
| 6250 | DLL1/NECTIN4 ratio | GCST90314497 | 0.85 |
| 6251 | Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levels | GCST90025735 | 0.85 |
| 6252 | CASP3 levels | GCST90468545 | 0.85 |
| 6253 | IDP dMRI ProbtrackX ICVF ar r | GCST90004376 | 0.85 |
| 6254 | Coronary atherosclerosis | circulatory system | UKBB00000152 | 0.85 |
| 6255 | aparc-a2009s lh volume G-precuneus | GCST90002954 | 0.85 |
| 6256 | RIDA levels | GCST90470469 | 0.85 |
| 6257 | CD69 levels | GCST90468643 | 0.85 |
| 6258 | BAG6 levels | GCST90468418 | 0.85 |
| 6259 | IL17D levels | GCST90469560 | 0.85 |
| 6260 | Paternal history of Alzheimer's disease | GCST005920 | 0.85 |
| 6261 | ACOX1/VSIR ratio | GCST90313155 | 0.85 |
| 6262 | IDP dMRI ProbtrackX L2 cgc r | GCST90004278 | 0.85 |
| 6263 | Triglycerides to total lipids in small VLDL percentage (UKB data field 23603) | GCST90269700 | 0.85 |
| 6264 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T404 | ECGA000404 | 0.85 |
| 6265 | Allergic disease (asthma, hay fever or eczema) | GCST005038 | 0.85 |
| 6266 | SRPK2 levels | GCST90470743 | 0.85 |
| 6267 | TDP1 levels | GCST90470826 | 0.85 |
| 6268 | IDP dMRI TBSS OD Superior corona radiata L | GCST90004427 | 0.85 |
| 6269 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T403 | ECGA000403 | 0.85 |
| 6270 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T103 | ECGA000103 | 0.84 |
| 6271 | F11 levels | GCST90469165 | 0.84 |
| 6272 | CC2D1A levels | GCST90468557 | 0.84 |
| 6273 | Treatment or medication use - amlodipine (UKB data field 20003_1140879802) | GCST90042195 | 0.84 |
| 6274 | Brain glioblastoma, excluding all cancers (controls excluding all cancers) | FING00000225 | 0.84 |
| 6275 | CA2/PSMG3 ratio | GCST90313581 | 0.84 |
| 6276 | Plasma X-24947 levels in chronic kidney disease | GCST90266816 | 0.84 |
| 6277 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364 | ECGU000364 | 0.84 |
| 6278 | IDP dMRI TBSS L3 Superior corona radiata L | GCST90004196 | 0.84 |
| 6279 | C7 levels | GCST90422332 | 0.84 |
| 6280 | Keloid | GCST90018654 | 0.84 |
| 6281 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145 | ECGU000145 | 0.84 |
| 6282 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392 | ECGU000392 | 0.84 |
| 6283 | APRT levels | GCST90468345 | 0.84 |
| 6284 | IDP dMRI TBSS MD Genu of corpus callosum | GCST90004029 | 0.84 |
| 6285 | PAEP/RSPO1 ratio | GCST90315593 | 0.84 |
| 6286 | IDP dMRI TBSS FA Superior corona radiata L | GCST90003902 | 0.84 |
| 6287 | Triacylglycerol_53:3_[M+NH4]1+ levels | GCST90060528 | 0.84 |
| 6288 | LACTB2 levels | GCST90469726 | 0.84 |
| 6289 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T492 | ECGU000492 | 0.84 |
| 6290 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T339 | ECGA000339 | 0.83 |
| 6291 | IDP dMRI TBSS MD Anterior corona radiata L | GCST90004050 | 0.83 |
| 6292 | SPINT2 levels | GCST90470728 | 0.83 |
| 6293 | IDP dMRI TBSS OD Posterior corona radiata R | GCST90004428 | 0.83 |
| 6294 | Right-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302848 | 0.83 |
| 6295 | Internal derangement of knee | injuries & poisonings | UKBB00000368 | 0.83 |
| 6296 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363 | ECGU000363 | 0.83 |
| 6297 | Principal component-derived dietary pattern 35 | GCST90133040 | 0.83 |
| 6298 | Eosinophil percentage of white cells | GCST90002382 | 0.83 |
| 6299 | Obesity | FING00000895 | 0.83 |
| 6300 | Oral glucose tolerance test-1h | GCST90297789 | 0.83 |
| 6301 | Lateral epicondylitis | FING00000715 | 0.83 |
| 6302 | CD69/TXNDC5 ratio | GCST90313889 | 0.83 |
| 6303 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T399 | ECGA000399 | 0.83 |
| 6304 | Weight-to-muscle ratio | GCST90267359 | 0.83 |
| 6305 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000812 | 0.83 |
| 6306 | CHMP1A levels | GCST90468746 | 0.83 |
| 6307 | aparc-a2009s rh area G-postcentral | GCST90003398 | 0.83 |
| 6308 | Breast size | GCST006655 | 0.83 |
| 6309 | IDP dMRI TBSS MD Superior longitudinal fasciculus R | GCST90004067 | 0.83 |
| 6310 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T402 | ECGA000402 | 0.83 |
| 6311 | AGXT/MME ratio | GCST90313207 | 0.83 |
| 6312 | Celiac disease (PheCode 557.1) | GCST90044158 | 0.83 |
| 6313 | IDP dMRI TBSS ISOVF Genu of corpus callosum | GCST90004479 | 0.83 |
| 6314 | rfMRI amplitudes (ICA100 node 12) | GCST90004600 | 0.83 |
| 6315 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 0.83 |
| 6316 | PROC levels | GCST90470335 | 0.83 |
| 6317 | ERBB2/GUSB ratio | GCST90314687 | 0.83 |
| 6318 | Glaucoma (PheCode 365) | GCST008373 | 0.83 |
| 6319 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21 | ECGU000021 | 0.83 |
| 6320 | Frequency of solarium/sunlamp use | Sun exposure | UKBB00000265 | 0.83 |
| 6321 | STAMBP levels | GCST90470756 | 0.83 |
| 6322 | High light scatter reticulocyte percentage (UKB data field 30290) | GCST90468077 | 0.83 |
| 6323 | Neutrophil percentage of granulocytes | GCST004623 | 0.82 |
| 6324 | Right-hemisphere control network to accumbens white-matter structural connectivity | GCST90302842 | 0.82 |
| 6325 | CDH17/GALNT3 ratio | GCST90313940 | 0.82 |
| 6326 | Stroke (MTAG) | GCST90449063 | 0.82 |
| 6327 | SVEP1 levels | GCST90242928 | 0.82 |
| 6328 | QC T2 FLAIR-to-T1 linear alignment discrepancy | GCST90006350 | 0.82 |
| 6329 | Volume of right central nucleus | GCST90475027 | 0.82 |
| 6330 | MINDY1 levels | GCST90469908 | 0.82 |
| 6331 | Chronic obstructive pulmonary disease x current smoker interaction (main effect) | GCST90016591 | 0.82 |
| 6332 | IDP dMRI TBSS L2 Posterior limb of internal capsule R | GCST90004141 | 0.82 |
| 6333 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T341 | ECGA000341 | 0.82 |
| 6334 | Hyperparathyroidism (PheCode 252.1) | GCST90475693 | 0.82 |
| 6335 | VPS53 levels | GCST90471048 | 0.82 |
| 6336 | Tobacco use disorder | mental disorders | UKBB00000824 | 0.82 |
| 6337 | Concentration of very small VLDL particles | GCST90093035 | 0.82 |
| 6338 | CD46/NECTIN2 ratio | GCST90313832 | 0.82 |
| 6339 | LEP levels | GCST90012076 | 0.82 |
| 6340 | X-21441 levels | GCST90200581 | 0.82 |
| 6341 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T124 | ECGU000124 | 0.82 |
| 6342 | Subarachnoid hemorrhage | GCST90018703 | 0.82 |
| 6343 | Prescriptions - alpha1-antagonist|alpha blocker | UKBB00000659 | 0.82 |
| 6344 | SNAP25 levels | GCST90422083 | 0.82 |
| 6345 | Gestational diabetes (for exclusion) | FING00000573 | 0.82 |
| 6346 | TBCA levels | GCST90470812 | 0.82 |
| 6347 | Phospholipids in small HDL | GCST90499478 | 0.82 |
| 6348 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T320 | ECGA000320 | 0.81 |
| 6349 | GGH/INHBC ratio | GCST90314928 | 0.81 |
| 6350 | DAPP1/PTPN6 ratio | GCST90314397 | 0.81 |
| 6351 | Cholesteryl ester_16:0_[M+NH4]1+ levels | GCST90060211 | 0.81 |
| 6352 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T398 | ECGA000398 | 0.81 |
| 6353 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 0.81 |
| 6354 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T330 | ECGA000330 | 0.81 |
| 6355 | Medication use (adrenergics, inhalants) | GCST90018779 | 0.81 |
| 6356 | Bone marrow fat fraction of left proximal femur | GCST90652392 | 0.81 |
| 6357 | CXCL16/NOTCH1 ratio | GCST90314339 | 0.81 |
| 6358 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463 | ECGA000463 | 0.81 |
| 6359 | AGR2 levels | GCST90468253 | 0.81 |
| 6360 | IDP dMRI TBSS OD Tapetum R | GCST90004448 | 0.81 |
| 6361 | VEGFC/ZBTB16 ratio | GCST90315946 | 0.81 |
| 6362 | Eicosenoylcarnitine (C20:1) levels | GCST90200148 | 0.81 |
| 6363 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271 | ECGU000271 | 0.81 |
| 6364 | PLIN3 levels | GCST90470259 | 0.81 |
| 6365 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T408 | ECGA000408 | 0.81 |
| 6366 | IDP dMRI TBSS FA Superior cerebellar peduncle L | GCST90003890 | 0.81 |
| 6367 | Central serous chorioretinopathy | GCST90268400 | 0.81 |
| 6368 | RWDD1 levels | GCST90470510 | 0.81 |
| 6369 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490 | ECGU000490 | 0.81 |
| 6370 | Right ventricular ejection fraction (MTAG) | GCST90134595 | 0.81 |
| 6371 | DRG2 levels | GCST90469039 | 0.81 |
| 6372 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T343 | ECGA000343 | 0.80 |
| 6373 | Enteritis due to Yersinia enterocolitica | FING00000505 | 0.80 |
| 6374 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T105 | ECGA000105 | 0.80 |
| 6375 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 0.80 |
| 6376 | IDP dMRI TBSS FA Superior corona radiata R | GCST90003901 | 0.80 |
| 6377 | Thick vs thin eyebrows | GCST006093 | 0.80 |
| 6378 | DBNL/HEXIM1 ratio | GCST90314417 | 0.80 |
| 6379 | CD160/CXCL16 ratio | GCST90313728 | 0.80 |
| 6380 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17 | ECGU000017 | 0.80 |
| 6381 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320887 | 0.80 |
| 6382 | VAV3 levels | GCST90471030 | 0.80 |
| 6383 | TBCC levels | GCST90470814 | 0.80 |
| 6384 | GPR15L levels | GCST90469396 | 0.80 |
| 6385 | ADM levels | GCST90468246 | 0.80 |
| 6386 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344 | ECGA000344 | 0.80 |
| 6387 | COLEC12 levels | GCST90468824 | 0.80 |
| 6388 | F3 levels | GCST90469170 | 0.80 |
| 6389 | aparc-a2009s rh thickness G+S-cingul-Ant | GCST90003682 | 0.80 |
| 6390 | CCR2 on CD14+ CD16- monocyte | GCST90002004 | 0.80 |
| 6391 | Insomnia (PheCode 327.4) | GCST90475826 | 0.79 |
| 6392 | CCER2 levels | GCST90468563 | 0.79 |
| 6393 | Episcleritis | FING00000513 | 0.79 |
| 6394 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T346 | ECGA000346 | 0.79 |
| 6395 | Symbol digit substitution test performance (baseline) | GCST90565841 | 0.79 |
| 6396 | Phospholipids in medium VLDL | GCST90499025 | 0.79 |
| 6397 | T1 FreeSurfer BA rh V2 exvivo area | GCST90385557 | 0.79 |
| 6398 | Family relationship satisfaction | Mental health | UKBB00000238 | 0.79 |
| 6399 | Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3) | GCST90043946 | 0.79 |
| 6400 | eosinophil (absolute count, maximum, inv-norm transformed) | GCST90475288 | 0.79 |
| 6401 | Docosahexaenoic acid to total fatty acids percentage | GCST90502268 | 0.79 |
| 6402 | Facial wrinkles (under eye) | GCST90094903 | 0.79 |
| 6403 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T275 | ECGA000275 | 0.79 |
| 6404 | MANF/SNX9 ratio | GCST90315368 | 0.79 |
| 6405 | DTI TBSS L3 Uncinate fasciculus R | GCST90384568 | 0.79 |
| 6406 | DLL1/NOTCH1 ratio | GCST90314498 | 0.79 |
| 6407 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131 | ECGU000131 | 0.79 |
| 6408 | PROS1 levels | GCST90470337 | 0.78 |
| 6409 | Nasal polyp | Other diseases of upper respiratory tract | UKBB00000493 | 0.78 |
| 6410 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96 | ECGU000096 | 0.78 |
| 6411 | IGFBP1 levels | GCST90469527 | 0.78 |
| 6412 | Tense / 'highly strung' | Mental health | UKBB00000815 | 0.78 |
| 6413 | aparc-a2009s rh area S-postcentral | GCST90003437 | 0.78 |
| 6414 | Right-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302799 | 0.78 |
| 6415 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320691 | 0.78 |
| 6416 | SIGLEC9 levels | GCST90470637 | 0.78 |
| 6417 | Myopia (PheCode 367.1) | GCST90475880 | 0.78 |
| 6418 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 0.78 |
| 6419 | Depressive episode | Mood [affective] disorders | UKBB00000166 | 0.78 |
| 6420 | Sum eosinophil basophil counts | GCST004624 | 0.78 |
| 6421 | EIF2AK2 levels | GCST90469091 | 0.78 |
| 6422 | ITGB1/TFPI ratio | GCST90315231 | 0.78 |
| 6423 | MSTN/RGMA ratio | GCST90315504 | 0.78 |
| 6424 | HSPG2/IGFBP6 ratio | GCST90315091 | 0.78 |
| 6425 | Hippocampal subfield left CA3 volume (head) | GCST90267941 | 0.78 |
| 6426 | SRC levels | GCST90470741 | 0.78 |
| 6427 | KRT8 levels | GCST90469720 | 0.78 |
| 6428 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 0.78 |
| 6429 | CA12 levels | GCST90468507 | 0.78 |
| 6430 | VNN2 levels | GCST90618510 | 0.78 |
| 6431 | CA1/CA2 ratio | GCST90313571 | 0.78 |
| 6432 | Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditions | UKBB00000518 | 0.78 |
| 6433 | Triacylglycerol (48:2) [NL-16:0] levels | GCST90025143 | 0.78 |
| 6434 | Other neurological diseases | FING00001074 | 0.78 |
| 6435 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498758 | 0.77 |
| 6436 | IDP dMRI ProbtrackX MO atr r | GCST90004003 | 0.77 |
| 6437 | Prescriptions - beta2-agonist|bronchodilator|asthma | UKBB00000670 | 0.77 |
| 6438 | Prescriptions - albuterol | beta2-agonist,bronchodilator,asthma | UKBB00000658 | 0.77 |
| 6439 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T318 | ECGA000318 | 0.77 |
| 6440 | Right ventricular stroke volume (MTAG) | GCST90134594 | 0.77 |
| 6441 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462 | ECGA000462 | 0.77 |
| 6442 | Handedness (chirality/laterality) - Right-handed | Early life factors | UKBB00000303 | 0.77 |
| 6443 | Arterial embolism and thrombosis of lower extremity artery | FING00000106 | 0.77 |
| 6444 | DTI TBSS L2 External capsule R | GCST90384508 | 0.77 |
| 6445 | Illnesses of father - None of the above (group 1) | Family history | UKBB00000345 | 0.77 |
| 6446 | DBI levels | GCST90468949 | 0.77 |
| 6447 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274 | ECGA000274 | 0.77 |
| 6448 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121 | ECGA000121 | 0.77 |
| 6449 | DPEP1 levels | GCST90090302 | 0.77 |
| 6450 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223 | ECGU000223 | 0.77 |
| 6451 | Prescriptions - thyroid hormone | hormone | UKBB00000705 | 0.77 |
| 6452 | Prescriptions - levothyroxine | thyroid hormone | UKBB00000687 | 0.77 |
| 6453 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T407 | ECGA000407 | 0.77 |
| 6454 | Hereditary ataxia | FING00000610 | 0.77 |
| 6455 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T126 | ECGU000126 | 0.77 |
| 6456 | aparc-a2009s rh volume S-postcentral | GCST90003065 | 0.77 |
| 6457 | EFEMP1/FSTL3 ratio | GCST90314595 | 0.77 |
| 6458 | FGF19/SCG2 ratio | GCST90314809 | 0.77 |
| 6459 | TRIM5 levels | GCST90470970 | 0.77 |
| 6460 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T331 | ECGA000331 | 0.77 |
| 6461 | BA-exvivo rh area BA45 | GCST90003229 | 0.77 |
| 6462 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T340 | ECGA000340 | 0.77 |
| 6463 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115 | ECGU000115 | 0.77 |
| 6464 | Visceral adipose tissue normalized | GCST90267358 | 0.76 |
| 6465 | LUZP2 levels | GCST90469819 | 0.76 |
| 6466 | Feeling guilty | GCST006945 | 0.76 |
| 6467 | TRAF2/WWP2 ratio | GCST90315943 | 0.76 |
| 6468 | Lawsonibacter sp002161175 abundance in stool | GCST90032459 | 0.76 |
| 6469 | AHCY/HSPA1A ratio | GCST90313211 | 0.76 |
| 6470 | TREML1 levels | GCST90470961 | 0.76 |
| 6471 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T319 | ECGA000319 | 0.76 |
| 6472 | COL6A3/COLEC12 ratio | GCST90314173 | 0.76 |
| 6473 | Systemic lupus erythematosus | GCST90014238 | 0.76 |
| 6474 | NCR3LG1 levels | GCST90470010 | 0.76 |
| 6475 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T322 | ECGU000322 | 0.76 |
| 6476 | Stool frequency | GCST90002250 | 0.76 |
| 6477 | Volume of right cortico-amygdaloid transition area | GCST90474913 | 0.76 |
| 6478 | Acute sinusitis | FING00000031 | 0.76 |
| 6479 | Use of dietary supplements (confirmatory factor analysis Factor 13) | GCST90309347 | 0.76 |
| 6480 | LBP levels | GCST90469743 | 0.76 |
| 6481 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459 | ECGA000459 | 0.76 |
| 6482 | Saturated fatty acids to total fatty acids percentage | GCST90502199 | 0.76 |
| 6483 | Cholesteryl esters in LDL (UKB data field 23417) | GCST90269514 | 0.76 |
| 6484 | Sleep apnoea | FING00001309 | 0.75 |
| 6485 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396 | ECGU000396 | 0.75 |
| 6486 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000444 | 0.75 |
| 6487 | Chronic obstructive pulmonary disease | GCST90018587 | 0.75 |
| 6488 | heart rate (HR, maximum, inv-normal transformed) | GCST90476334 | 0.75 |
| 6489 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T326 | ECGA000326 | 0.75 |
| 6490 | KRT18 levels | GCST90469716 | 0.75 |
| 6491 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 0.75 |
| 6492 | PRSS22 levels | GCST90470341 | 0.75 |
| 6493 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T34 | ECGU000034 | 0.75 |
| 6494 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320684 | 0.75 |
| 6495 | NUDT5 levels | GCST90470107 | 0.75 |
| 6496 | Propionylcarnitine levels | GCST90243593 | 0.75 |
| 6497 | IMMT levels | GCST90469609 | 0.75 |
| 6498 | TNFSF11 levels | GCST90274844 | 0.75 |
| 6499 | PRG2 levels | GCST90470322 | 0.75 |
| 6500 | Left ventricular wall thickness (maximal) | GCST90435263 | 0.75 |
| 6501 | Total bilirubin levels (UKB data field 30840) | GCST90468104 | 0.75 |
| 6502 | Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044) | GCST90042535 | 0.75 |
| 6503 | AXIN1/IKBKG ratio | GCST90313409 | 0.75 |
| 6504 | T1 CAT volume Vermis VIIIa | GCST90384128 | 0.75 |
| 6505 | SPINK4 levels | GCST90470723 | 0.75 |
| 6506 | Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary Administration | UKBB00000464 | 0.75 |
| 6507 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T345 | ECGA000345 | 0.74 |
| 6508 | CGREF1/FAM3C ratio | GCST90314032 | 0.74 |
| 6509 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 0.74 |
| 6510 | Liver proton density fat fraction | GCST90267352 | 0.74 |
| 6511 | Umbilical hernia | FING00001395 | 0.74 |
| 6512 | REST UKBBICA NET100 1111 | GCST90386965 | 0.74 |
| 6513 | aparc-DKTatlas rh area precentral | GCST90003287 | 0.74 |
| 6514 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T139 | ECGU000139 | 0.74 |
| 6515 | Heart failure, strict | FING00000606 | 0.74 |
| 6516 | Pain in joint (PheCode 745) | GCST90476262 | 0.74 |
| 6517 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144 | ECGU000144 | 0.74 |
| 6518 | Other and unspecified disorders of vitreous body | FING00000934 | 0.74 |
| 6519 | aseg lh intensity Lateral-Ventricle | GCST90003764 | 0.74 |
| 6520 | TDGF1 levels | GCST90470824 | 0.74 |
| 6521 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25) | GCST90320588 | 0.74 |
| 6522 | ICA1 levels | GCST90469497 | 0.74 |
| 6523 | Skin red/green component | GCST90320258 | 0.74 |
| 6524 | ENO2/MANF ratio | GCST90314662 | 0.74 |
| 6525 | wg rh intensity-contrast lateralorbitofrontal | GCST90003838 | 0.74 |
| 6526 | aseg lh volume Putamen | GCST90002622 | 0.73 |
| 6527 | Blood cell traits latent factor 16 (white cell) | GCST90559258 | 0.73 |
| 6528 | CEP85 levels | GCST90468716 | 0.73 |
| 6529 | YAP1 levels | GCST90471086 | 0.73 |
| 6530 | Flavonifractor sp002159265 abundance in stool | GCST90032400 | 0.73 |
| 6531 | F-small fish liking (derived food-liking factor) | GCST90094840 | 0.73 |
| 6532 | Volume of right cortico-amygdaloid transition area | GCST90474911 | 0.73 |
| 6533 | Hypothyroidism, drug reimbursement | FING00000655 | 0.73 |
| 6534 | IMPACT levels | GCST90469611 | 0.73 |
| 6535 | Takes medication for asthma? | GCST90475260 | 0.73 |
| 6536 | IDP T1 FAST ROIs V cerebellum crus II | GCST90002573 | 0.73 |
| 6537 | NTF3 levels | GCST90470094 | 0.73 |
| 6538 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28 | ECGU000028 | 0.73 |
| 6539 | CHCHD10 levels | GCST90468738 | 0.73 |
| 6540 | CNPY4/ERBIN ratio | GCST90314148 | 0.73 |
| 6541 | Ventral hernia | FING00001428 | 0.73 |
| 6542 | IDP dMRI TBSS OD Fornix | GCST90004407 | 0.73 |
| 6543 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 0.73 |
| 6544 | CTSF/CTSV ratio | GCST90314313 | 0.73 |
| 6545 | Myocardial fractal dimension (slice 3) | GCST90000289 | 0.73 |
| 6546 | Clonal haematopoiesis of indeterminate potential (ASXL1 mutation) | GCST90165259 | 0.73 |
| 6547 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474 | ECGA000474 | 0.73 |
| 6548 | Hypothyroidism | endocrine/metabolic | UKBB00000335 | 0.73 |
| 6549 | Insulin fold change during an oral glucose tolerance test (adjusted for BMI) | GCST90267567 | 0.73 |
| 6550 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487 | ECGU000487 | 0.72 |
| 6551 | Osteoporosis | GCST90086122 | 0.72 |
| 6552 | Medication for pain relief, constipation, heartburn - Paracetamol | Medication | UKBB00000459 | 0.72 |
| 6553 | Major depressive disorder | GCST009979 | 0.72 |
| 6554 | ZNRF4 levels | GCST90471104 | 0.72 |
| 6555 | Plasma ascorbic acid 2-sulfate levels in chronic kidney disease | GCST90264832 | 0.72 |
| 6556 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97 | ECGU000097 | 0.72 |
| 6557 | PECAM1 levels | GCST90470206 | 0.72 |
| 6558 | JAM3 levels | GCST90469660 | 0.72 |
| 6559 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63 | ECGA000063 | 0.72 |
| 6560 | Happiness | Mental health | UKBB00000305 | 0.72 |
| 6561 | Levulinate 4-oxovalerate levels | GCST90243545 | 0.72 |
| 6562 | Medical abortion | FING00000796 | 0.72 |
| 6563 | CD84/TREML2 ratio | GCST90313919 | 0.72 |
| 6564 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T310 | ECGA000310 | 0.72 |
| 6565 | Platelet count during first trimester of pregnancy | GCST90302224 | 0.72 |
| 6566 | COLEC12/OGN ratio | GCST90314184 | 0.72 |
| 6567 | Childhood maltreatment | GCST90551844 | 0.72 |
| 6568 | RWDD1/SUMF2 ratio | GCST90315795 | 0.72 |
| 6569 | ACRBP levels | GCST90468205 | 0.72 |
| 6570 | Do you currently smoke cigarettes? | GCST90476388 | 0.72 |
| 6571 | Hair colour (natural, before greying) - Black | Sun exposure | UKBB00000295 | 0.72 |
| 6572 | Sleep disorders (PheCode 327) | GCST90475823 | 0.72 |
| 6573 | Red meat liking | GCST90094819 | 0.72 |
| 6574 | NCR1 levels | GCST90090153 | 0.72 |
| 6575 | Maximum workload during fitness test | ECG during exercise | UKBB00000432 | 0.71 |
| 6576 | CELA3A/PLA2G1B ratio | GCST90314014 | 0.71 |
| 6577 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475 | ECGA000475 | 0.71 |
| 6578 | Spondyloarthritis | FING00001323 | 0.71 |
| 6579 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422 | ECGU000422 | 0.71 |
| 6580 | Cholesterol levels in small LDL | GCST90092956 | 0.71 |
| 6581 | Spread type: Butter/spreadable butter (UKB data field 1428_1) | GCST90132953 | 0.71 |
| 6582 | MZB1/TNFRSF13B ratio | GCST90315509 | 0.71 |
| 6583 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T299 | ECGU000299 | 0.71 |
| 6584 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T324 | ECGA000324 | 0.71 |
| 6585 | Mineral and other dietary supplements - Zinc | Medication | UKBB00000476 | 0.71 |
| 6586 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T317 | ECGA000317 | 0.71 |
| 6587 | Treatment/medication code - aspirin | Medications | UKBB00000841 | 0.71 |
| 6588 | Patient classification on admission (recoded) - Inpatient | Summary Administration | UKBB00000637 | 0.71 |
| 6589 | Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenum | UKBB00000606 | 0.71 |
| 6590 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 0.71 |
| 6591 | aseg rh intensity Pallidum | GCST90003785 | 0.71 |
| 6592 | Heart valve replaced (PheCode 395.6) | GCST90475915 | 0.71 |
| 6593 | FABP1/SULT2A1 ratio | GCST90314755 | 0.71 |
| 6594 | AFM levels | GCST90468249 | 0.71 |
| 6595 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95 | ECGU000095 | 0.71 |
| 6596 | PIBF1 levels | GCST90470231 | 0.71 |
| 6597 | Degeneration of intervertebral disc (PheCode 722.6) | GCST90476238 | 0.71 |
| 6598 | Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivity | GCST90302792 | 0.71 |
| 6599 | AHSP/BLVRB ratio | GCST90313214 | 0.70 |
| 6600 | GBP6 levels | GCST90241368 | 0.70 |
| 6601 | LDL cholesterol | GCST002222 | 0.70 |
| 6602 | Number of vehicles in household | Household | UKBB00000543 | 0.70 |
| 6603 | SCARA5/SCARF2 ratio | GCST90315808 | 0.70 |
| 6604 | IDP dMRI TBSS L3 Anterior corona radiata R | GCST90004193 | 0.70 |
| 6605 | Acute laryngitis and tracheitis | FING00000023 | 0.70 |
| 6606 | Cancer within the respiratory system (PheCode 165) | GCST90475571 | 0.70 |
| 6607 | CCL17/PDGFB ratio | GCST90313688 | 0.70 |
| 6608 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59 | ECGA000059 | 0.70 |
| 6609 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T272 | ECGU000272 | 0.70 |
| 6610 | Triacylglycerol_51:4_[M+NH4]1+ levels | GCST90060491 | 0.70 |
| 6611 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T338 | ECGA000338 | 0.70 |
| 6612 | Unspecified acute lower respiratory infection | FING00001398 | 0.70 |
| 6613 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57 | ECGA000057 | 0.70 |
| 6614 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135 | ECGU000135 | 0.70 |
| 6615 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499804 | 0.70 |
| 6616 | ALDH1A1/RBKS ratio | GCST90313247 | 0.70 |
| 6617 | DTI TBSS MD Superior fronto-occipital fasciculus R | GCST90384614 | 0.70 |
| 6618 | aseg global volume SupraTentorialNotVent | GCST90002596 | 0.70 |
| 6619 | Triacylglycerol_51:2_[M+NH4]1+ levels | GCST90060497 | 0.70 |
| 6620 | PDGFB/ST6GAL1 ratio | GCST90315630 | 0.70 |
| 6621 | Eosinophil percentage of granulocytes | GCST004617 | 0.70 |
| 6622 | GOLM2/STC1 ratio | GCST90314952 | 0.70 |
| 6623 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) | GCST90092984 | 0.70 |
| 6624 | Glycine levels | GCST90200707 | 0.70 |
| 6625 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 0.70 |
| 6626 | DTI TBSS FA Posterior limb of internal capsule R | GCST90384398 | 0.70 |
| 6627 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T276 | ECGA000276 | 0.70 |
| 6628 | Systolic blood pressure | GCST90018752 | 0.70 |
| 6629 | Smoked fish liking | GCST90094841 | 0.70 |
| 6630 | CDH17/DSG2 ratio | GCST90313939 | 0.70 |
| 6631 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T298 | ECGA000298 | 0.70 |
| 6632 | Disorders of plasma protein metabolism (PheCode 270.3) | GCST90475709 | 0.70 |
| 6633 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T321 | ECGU000321 | 0.70 |
| 6634 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499044 | 0.69 |
| 6635 | HGS levels | GCST90469450 | 0.69 |
| 6636 | APEX1 levels | GCST90468329 | 0.69 |
| 6637 | REST UKBBICA NODEamps25 0014 | GCST90385497 | 0.69 |
| 6638 | Rheumatoid arthritis | GCST90132223 | 0.69 |
| 6639 | Treatment or medication use - atorvastatin (UKB data field 20003_1141146234) | GCST90042376 | 0.69 |
| 6640 | LEP levels | GCST90469757 | 0.69 |
| 6641 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 0.69 |
| 6642 | Urticaria | FING00001408 | 0.69 |
| 6643 | Disorders of vitreous body | FING00000465 | 0.69 |
| 6644 | Asthma-related pneumonia | FING00000119 | 0.69 |
| 6645 | Eosinophill percentage | Blood count | UKBB00000207 | 0.69 |
| 6646 | Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3) | GCST90475983 | 0.69 |
| 6647 | IDP dMRI ProbtrackX L3 ilf l | GCST90004314 | 0.69 |
| 6648 | PEAR1/SNAP23 ratio | GCST90315643 | 0.69 |
| 6649 | IDP dMRI TBSS L2 Superior longitudinal fasciculus R | GCST90004163 | 0.69 |
| 6650 | SLPI levels | GCST90426030 | 0.69 |
| 6651 | Cervical disc disorders | FING00000265 | 0.69 |
| 6652 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T325 | ECGA000325 | 0.69 |
| 6653 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320655 | 0.69 |
| 6654 | CDHR2/MME ratio | GCST90313963 | 0.68 |
| 6655 | Left ventricular end-diastolic volume | GCST90268124 | 0.68 |
| 6656 | F2R/SEMA4D ratio | GCST90314734 | 0.68 |
| 6657 | ATP5IF1/LYN ratio | GCST90313389 | 0.68 |
| 6658 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 0.68 |
| 6659 | Aplastic anemia (PheCode 284) | GCST90475783 | 0.68 |
| 6660 | Birth asphyxia | FING00000218 | 0.68 |
| 6661 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320885 | 0.68 |
| 6662 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T300 | ECGU000300 | 0.68 |
| 6663 | Other diseases of liver | FING00001004 | 0.68 |
| 6664 | Right ventricular stroke volume | GCST90268122 | 0.68 |
| 6665 | Cognitive processing speed | GCST90446168 | 0.68 |
| 6666 | Salami liking | GCST90094825 | 0.68 |
| 6667 | Bullous keratopathy | FING00000231 | 0.68 |
| 6668 | AXIN1/MAVS ratio | GCST90313414 | 0.68 |
| 6669 | Basal cell carcinoma, excluding all cancers (controls excluding all cancers) | FING00000142 | 0.68 |
| 6670 | NPDC1/TAFA5 ratio | GCST90315550 | 0.68 |
| 6671 | Qualifications - A levels/AS levels or equivalent | Education | UKBB00000727 | 0.68 |
| 6672 | Other disorders of eyelid | FING00001026 | 0.68 |
| 6673 | aseg global volume SupraTentorial | GCST90002595 | 0.68 |
| 6674 | Ischemic stroke | GCST006908 | 0.68 |
| 6675 | AXIN1/DOK2 ratio | GCST90313406 | 0.68 |
| 6676 | Other forms of systemic lupus erythematosus | FING00001051 | 0.68 |
| 6677 | Collagenous colitis | GCST90204145 | 0.67 |
| 6678 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T361 | ECGU000361 | 0.67 |
| 6679 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T323 | ECGU000323 | 0.67 |
| 6680 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457 | ECGA000457 | 0.67 |
| 6681 | TNFRSF1A levels | GCST90012015 | 0.67 |
| 6682 | SELPLG levels | GCST90012046 | 0.67 |
| 6683 | Neuroticism | GCST005232 | 0.67 |
| 6684 | Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) | GCST90269690 | 0.67 |
| 6685 | SPON2 levels | GCST90470732 | 0.67 |
| 6686 | FKBP5/MAP4K5 ratio | GCST90314843 | 0.67 |
| 6687 | Cholesterol levels in very small VLDL | GCST90093028 | 0.67 |
| 6688 | RFC4 levels | GCST90470460 | 0.67 |
| 6689 | Aortic aneurysm | FING00000102 | 0.67 |
| 6690 | IPCEF1 levels | GCST90469624 | 0.67 |
| 6691 | CALCOCO1/IKBKG ratio | GCST90313602 | 0.67 |
| 6692 | CXCL5/PPIB ratio | GCST90314352 | 0.67 |
| 6693 | Other and unspecified urticaria | FING00000957 | 0.67 |
| 6694 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T58 | ECGU000058 | 0.67 |
| 6695 | Other cancer | GCST90475181 | 0.67 |
| 6696 | GZMA/GZMB ratio | GCST90315007 | 0.67 |
| 6697 | Atrial flutter (PheCode 427.22) | GCST90475973 | 0.67 |
| 6698 | Paraproteinemia (PheCode 270.32) | GCST90475710 | 0.67 |
| 6699 | TRIM25 levels | GCST90470966 | 0.67 |
| 6700 | STAT5B levels | GCST90470759 | 0.67 |
| 6701 | Eosinophil count | GCST004606 | 0.67 |
| 6702 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466 | ECGA000466 | 0.67 |
| 6703 | White bread liking | GCST90094865 | 0.66 |
| 6704 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86 | ECGU000086 | 0.66 |
| 6705 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T150 | ECGU000150 | 0.66 |
| 6706 | Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731) | GCST90476246 | 0.66 |
| 6707 | LYN/TACC3 ratio | GCST90315350 | 0.66 |
| 6708 | Nervonoylcarnitine (C24:1) levels | GCST90200143 | 0.66 |
| 6709 | SLITRK2 levels | GCST90470670 | 0.66 |
| 6710 | Other specified cardiac dysrhythmias (PheCode 427.3) | GCST90475975 | 0.66 |
| 6711 | Body fat rate | GCST90278619 | 0.66 |
| 6712 | PRTFDC1 levels | GCST90470346 | 0.66 |
| 6713 | Principal component-derived dietary pattern 7 | GCST90133012 | 0.66 |
| 6714 | Pre-eclampsia or poor fetal growth | FING00001202 | 0.66 |
| 6715 | CA2/UBAC1 ratio | GCST90313583 | 0.66 |
| 6716 | Autorefraction - 3mm asymmetry angle (left) | Eyesight | UKBB00000060 | 0.66 |
| 6717 | aparc-Desikan lh volume superiorparietal | GCST90002796 | 0.66 |
| 6718 | CD58/ERBB3 ratio | GCST90313848 | 0.66 |
| 6719 | Glycated hemoglobin levels | GCST90002244 | 0.66 |
| 6720 | Soya milk liking | GCST90094845 | 0.66 |
| 6721 | Eosinophill percentage (UKB data field 30210) | GCST90468069 | 0.66 |
| 6722 | MME/NT5E ratio | GCST90315460 | 0.66 |
| 6723 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395 | ECGU000395 | 0.65 |
| 6724 | Urinary albumin excretion | GCST006586 | 0.65 |
| 6725 | DPEP2 levels | GCST90469031 | 0.65 |
| 6726 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134 | ECGU000134 | 0.65 |
| 6727 | CD40LG/GP6 ratio | GCST90313822 | 0.65 |
| 6728 | Histidine levels | GCST90092830 | 0.65 |
| 6729 | CCN3 levels | GCST90468589 | 0.65 |
| 6730 | GET3 levels | GCST90469324 | 0.65 |
| 6731 | BCAM/NOTCH1 ratio | GCST90313474 | 0.65 |
| 6732 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 0.65 |
| 6733 | Spermatocele (PheCode 603.2) | GCST90476158 | 0.65 |
| 6734 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102) | GCST90320665 | 0.65 |
| 6735 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T57 | ECGU000057 | 0.65 |
| 6736 | PARK7 levels | GCST90470159 | 0.65 |
| 6737 | DTI autoptx L2 fmi tract | GCST90385177 | 0.65 |
| 6738 | 4-androsten-3beta,17beta-diol disulfate 1 levels | GCST90243879 | 0.65 |
| 6739 | Unruptured cerebral aneurysm | GCST90018596 | 0.65 |
| 6740 | F-fish liking (derived food-liking factor) | GCST90094762 | 0.64 |
| 6741 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T149 | ECGU000149 | 0.64 |
| 6742 | HYOU1 levels | GCST90469496 | 0.64 |
| 6743 | EIF4EBP1 levels | GCST90469095 | 0.64 |
| 6744 | FAS levels | GCST90090701 | 0.64 |
| 6745 | Substance abuse (more control exclusions) | FING00001341 | 0.64 |
| 6746 | Dermatomycosis (PheCode 110.2) | GCST90475565 | 0.64 |
| 6747 | LGALS4/TIE1 ratio | GCST90315316 | 0.64 |
| 6748 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T148 | ECGU000148 | 0.64 |
| 6749 | SERPINA11 levels | GCST90470580 | 0.64 |
| 6750 | Migraine headaches | GCST90475546 | 0.64 |
| 6751 | CEBPB/PXN ratio | GCST90314008 | 0.64 |
| 6752 | Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers) | FING00000772 | 0.64 |
| 6753 | Lymphoid neoplasms (B-cell phenocluster) | GCST90624736 | 0.64 |
| 6754 | Coronary atherosclerosis | FING00000359 | 0.64 |
| 6755 | FXN/METAP1D ratio | GCST90314897 | 0.64 |
| 6756 | Avoided activities or situations because of previous stressful experience in past month | Traumatic events | UKBB00000083 | 0.64 |
| 6757 | Nasal polyps (PheCode 471) | GCST90476019 | 0.64 |
| 6758 | Pre-eclampsia or eclampsia | FING00001201 | 0.64 |
| 6759 | Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARB | UKBB00000662 | 0.64 |
| 6760 | IL6ST/TYRO3 ratio | GCST90315170 | 0.64 |
| 6761 | PTS levels | GCST90470390 | 0.64 |
| 6762 | Skin cancer | neoplasms | UKBB00000772 | 0.64 |
| 6763 | Ratio of docosahexaenoic acid to total fatty acid levels | GCST90092817 | 0.64 |
| 6764 | CX3CL1/PODXL2 ratio | GCST90314326 | 0.64 |
| 6765 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T35 | ECGU000035 | 0.64 |
| 6766 | Cardiac dysrhythmias | circulatory system | UKBB00000119 | 0.64 |
| 6767 | NFATC3 levels | GCST90470034 | 0.64 |
| 6768 | MANSC1/PODXL ratio | GCST90315372 | 0.64 |
| 6769 | Depression or dysthymia | FING00000400 | 0.64 |
| 6770 | Loneliness, isolation | Mental health | UKBB00000408 | 0.63 |
| 6771 | GYS1/PPP1R2 ratio | GCST90315001 | 0.63 |
| 6772 | COPD | FING00000350 | 0.63 |
| 6773 | FAM13A levels | GCST90469181 | 0.63 |
| 6774 | TXLNA levels | GCST90470989 | 0.63 |
| 6775 | Deviated nasal septum | FING00000409 | 0.63 |
| 6776 | IDP T1 FAST ROIs L cerebellum crus I | GCST90002569 | 0.63 |
| 6777 | 2-aminobutyrate levels | GCST90243584 | 0.63 |
| 6778 | PGLYRP2 levels | GCST90470220 | 0.63 |
| 6779 | SIRT2/STAT5B ratio | GCST90315846 | 0.63 |
| 6780 | Gout | GCST90399701 | 0.63 |
| 6781 | IDP dMRI ProbtrackX ISOVF ar r | GCST90004526 | 0.63 |
| 6782 | X-26109 levels | GCST90200671 | 0.63 |
| 6783 | Left-hemisphere control network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302747 | 0.63 |
| 6784 | ICAM3/LY9 ratio | GCST90315121 | 0.63 |
| 6785 | Osteoarthrosis (PheCode 740) | GCST90476253 | 0.63 |
| 6786 | ACY1/DCXR ratio | GCST90313162 | 0.63 |
| 6787 | Principal component-derived dietary pattern 46 | GCST90133051 | 0.63 |
| 6788 | Taking other prescription medications | Medication | UKBB00000813 | 0.63 |
| 6789 | Cancer of kidney and renal pelvis (PheCode 189.1) | GCST90475595 | 0.63 |
| 6790 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393 | ECGU000393 | 0.62 |
| 6791 | Other arthritis (FG) | FING00000964 | 0.62 |
| 6792 | IDP dMRI ProbtrackX MD ptr r | GCST90004239 | 0.62 |
| 6793 | Respiratory disease (confirmatory factor analysis Factor 11) | GCST90309345 | 0.62 |
| 6794 | RNF43 levels | GCST90470486 | 0.62 |
| 6795 | Spleen volume | GCST90016667 | 0.62 |
| 6796 | T1 CAT volume L VIIIa | GCST90384127 | 0.62 |
| 6797 | IDP dMRI TBSS L1 Anterior corona radiata R | GCST90004097 | 0.62 |
| 6798 | SAMD9L levels | GCST90470524 | 0.62 |
| 6799 | Mineral and other dietary supplements - None of the above | Medication | UKBB00000474 | 0.62 |
| 6800 | CD40LG/TRAF2 ratio | GCST90313828 | 0.62 |
| 6801 | Heart rate variability (root mean square of successive differences) | GCST90281263 | 0.62 |
| 6802 | aparc-DKTatlas lh volume superiorparietal | GCST90002889 | 0.62 |
| 6803 | TXNL1 levels | GCST90470993 | 0.62 |
| 6804 | Chronic airway obstruction | respiratory | UKBB00000135 | 0.62 |
| 6805 | IDP dMRI TBSS ICVF Middle cerebellar peduncle | GCST90004327 | 0.62 |
| 6806 | High light scatter reticulocyte percentage of red cells | GCST90002386 | 0.62 |
| 6807 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273 | ECGA000273 | 0.62 |
| 6808 | SCRN1 levels | GCST90470556 | 0.62 |
| 6809 | SIRT2 levels | GCST90470642 | 0.62 |
| 6810 | Type 1 diabetes | GCST90000529 | 0.62 |
| 6811 | Estradiol levels | GCST90012105 | 0.62 |
| 6812 | Metabolonic lactone sulfate levels | GCST90200257 | 0.61 |
| 6813 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471 | ECGA000471 | 0.61 |
| 6814 | DTI autoptx L3 cgc r tract | GCST90385198 | 0.61 |
| 6815 | Intelligence | GCST004364 | 0.61 |
| 6816 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175 | ECGA000175 | 0.61 |
| 6817 | LZTFL1 levels | GCST90469834 | 0.61 |
| 6818 | Humerus length to body height ratio | GCST90270259 | 0.61 |
| 6819 | Disorders of orbit | FING00000449 | 0.61 |
| 6820 | KLK15 levels | GCST90469701 | 0.61 |
| 6821 | CXCL16 levels | GCST90468928 | 0.61 |
| 6822 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 67) | GCST90320886 | 0.61 |
| 6823 | SARG levels | GCST90470526 | 0.61 |
| 6824 | Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels | GCST90060261 | 0.61 |
| 6825 | Cancer of liver and intrahepatic bile duct (PheCode 155) | GCST90475568 | 0.61 |
| 6826 | Butyrylcarnitine levels | GCST90243589 | 0.61 |
| 6827 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174 | ECGA000174 | 0.61 |
| 6828 | IDP dMRI ProbtrackX MD ptr l | GCST90004238 | 0.61 |
| 6829 | IDP SWI T2star right thalamus | GCST90003864 | 0.61 |
| 6830 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27 | ECGU000027 | 0.61 |
| 6831 | Volume of right central nucleus | GCST90474916 | 0.61 |
| 6832 | T1 FreeSurfer BA rh V1 exvivo area | GCST90385556 | 0.61 |
| 6833 | HLA-DMA levels | GCST90241448 | 0.61 |
| 6834 | CD200R1 levels | GCST90468605 | 0.60 |
| 6835 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417 | ECGU000417 | 0.60 |
| 6836 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394 | ECGU000394 | 0.60 |
| 6837 | EPS8L2 levels | GCST90469138 | 0.60 |
| 6838 | Ever smoked | Smoking | UKBB00000221 | 0.60 |
| 6839 | SCAMP3/STX4 ratio | GCST90315805 | 0.60 |
| 6840 | Cardiovascular delta age (difference between ECG-predicted and chronological age) | GCST90239749 | 0.60 |
| 6841 | Insulin fold change during an oral glucose tolerance test | GCST90267568 | 0.60 |
| 6842 | EPCAM/GPA33 ratio | GCST90314674 | 0.60 |
| 6843 | CRELD2/ERP44 ratio | GCST90314253 | 0.60 |
| 6844 | TNFRSF17 levels | GCST90470908 | 0.60 |
| 6845 | MANSC1 levels | GCST90469847 | 0.60 |
| 6846 | wg lh intensity-contrast isthmuscingulate | GCST90003801 | 0.60 |
| 6847 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62 | ECGA000062 | 0.60 |
| 6848 | SPINT1 levels | GCST90470727 | 0.60 |
| 6849 | X-12095--N1-methyl-3-pyridone-4-carboxamide levels | GCST90243701 | 0.60 |
| 6850 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T337 | ECGA000337 | 0.60 |
| 6851 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T329 | ECGA000329 | 0.60 |
| 6852 | wg rh intensity-contrast precuneus | GCST90003851 | 0.60 |
| 6853 | P4HB levels | GCST90470140 | 0.60 |
| 6854 | Anomalies of dental arch relationship, including avohilmo | FING00000091 | 0.60 |
| 6855 | MED18/TACC3 ratio | GCST90315414 | 0.60 |
| 6856 | Right bundle branch block (PheCode 426.31) | GCST90475957 | 0.60 |
| 6857 | AmygNuclei rh volume Lateral-nucleus | GCST90002658 | 0.60 |
| 6858 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22 | ECGU000022 | 0.60 |
| 6859 | GP6/SELP ratio | GCST90314970 | 0.60 |
| 6860 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178 | ECGA000178 | 0.60 |
| 6861 | Triacylglycerol_56:5_[M+NH4]1+ levels | GCST90060554 | 0.60 |
| 6862 | CST3 levels | GCST90468894 | 0.60 |
| 6863 | Fluid intelligence score decline (log-difference score) | GCST90565852 | 0.60 |
| 6864 | IDP dMRI TBSS MD Superior corona radiata L | GCST90004052 | 0.60 |
| 6865 | Citrulline levels | GCST90200403 | 0.59 |
| 6866 | Autorefraction - 3mm strong meridian angle (right) | Eyesight | UKBB00000068 | 0.59 |
| 6867 | GLOD4 levels | GCST90469359 | 0.59 |
| 6868 | ICD10 O60: Preterm labor and delivery | GCST90454242 | 0.59 |
| 6869 | CGREF1 levels | GCST90468735 | 0.59 |
| 6870 | Creatinine levels | GCST90132719 | 0.59 |
| 6871 | FGD3 levels | GCST90469217 | 0.59 |
| 6872 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 0.59 |
| 6873 | REN levels | GCST90470454 | 0.59 |
| 6874 | Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified | FING00000432 | 0.59 |
| 6875 | CRNN levels | GCST90277890 | 0.59 |
| 6876 | T1 CAT volume R TemporalFusiformCortexposteriordivision | GCST90384075 | 0.59 |
| 6877 | IDP dMRI TBSS ISOVF Superior cerebellar peduncle L | GCST90004490 | 0.59 |
| 6878 | HNRNPUL1 levels | GCST90469470 | 0.59 |
| 6879 | FOLH1 levels | GCST90241272 | 0.59 |
| 6880 | Illnesses of father - Lung cancer | Family history | UKBB00000344 | 0.59 |
| 6881 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T285 | ECGU000285 | 0.59 |
| 6882 | HSD11B1/SMPD1 ratio | GCST90315082 | 0.59 |
| 6883 | Bursitis (PheCode 726.3) | GCST90476240 | 0.59 |
| 6884 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228 | ECGA000228 | 0.59 |
| 6885 | RET levels | GCST90470458 | 0.59 |
| 6886 | Epstein-Barr virus EA-D antibody levels | GCST90006898 | 0.59 |
| 6887 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T493 | ECGU000493 | 0.59 |
| 6888 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 0.59 |
| 6889 | NTN4 levels | GCST90242049 | 0.59 |
| 6890 | DHEAS levels | GCST90199673 | 0.59 |
| 6891 | Disorders of ocular muscles, binocular movement, accommodation and refraction | FING00000446 | 0.59 |
| 6892 | Pregnancy hypertension | FING00001204 | 0.58 |
| 6893 | Cough on most days | Medical information | UKBB00000153 | 0.58 |
| 6894 | X-21736 levels | GCST90200584 | 0.58 |
| 6895 | Left-hemisphere limbic network to amygdala white-matter structural connectivity | GCST90302741 | 0.58 |
| 6896 | Non-cancer illness code, self-reported - gout | Medical conditions | UKBB00000512 | 0.58 |
| 6897 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T290 | ECGU000290 | 0.58 |
| 6898 | Age started wearing glasses or contact lenses | Eyesight | UKBB00000017 | 0.58 |
| 6899 | EPO levels | GCST90469136 | 0.58 |
| 6900 | Creatinine levels | GCST90092815 | 0.58 |
| 6901 | DSG3/DSG4 ratio | GCST90314558 | 0.58 |
| 6902 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T333 | ECGA000333 | 0.58 |
| 6903 | CHMP6 levels | GCST90468747 | 0.58 |
| 6904 | Serum copper levels | GCST90100524 | 0.58 |
| 6905 | OGA levels | GCST90470117 | 0.58 |
| 6906 | IFNGR1 levels | GCST90469513 | 0.58 |
| 6907 | GLRX5 levels | GCST90469361 | 0.58 |
| 6908 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358 | ECGU000358 | 0.58 |
| 6909 | Octadecenedioylcarnitine (C18:1-DC) levels | GCST90199970 | 0.58 |
| 6910 | T1 CAT volume L LeftAccumbens | GCST90384108 | 0.58 |
| 6911 | Spread type: Butter and margarine vs never use spread (UKB data field 1428) | GCST90132948 | 0.58 |
| 6912 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 0.58 |
| 6913 | Sphingomyelin_34:1_[M+H]1+ levels | GCST90060239 | 0.58 |
| 6914 | Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney disease | GCST90265671 | 0.58 |
| 6915 | CCL22/TIMP3 ratio | GCST90313693 | 0.58 |
| 6916 | THTPA levels | GCST90470860 | 0.58 |
| 6917 | IDP dMRI TBSS L2 Fornix | GCST90004128 | 0.58 |
| 6918 | Principal component-derived dietary pattern 39 | GCST90133044 | 0.58 |
| 6919 | Chronic obstructive pulmonary disease in current smokers | GCST90016593 | 0.58 |
| 6920 | TGFBI/VASN ratio | GCST90315915 | 0.58 |
| 6921 | Thyroid problems | GCST90475276 | 0.57 |
| 6922 | IDP dMRI ProbtrackX L2 ptr r | GCST90004293 | 0.57 |
| 6923 | Serum phosphate levels | GCST90025948 | 0.57 |
| 6924 | MGLL levels | GCST90469901 | 0.57 |
| 6925 | 1,5-anhydroglucitol (1,5-ag) levels | GCST90243529 | 0.57 |
| 6926 | Eosinophil percentage of white cells | GCST004600 | 0.57 |
| 6927 | ADGRG1 levels | GCST90468240 | 0.57 |
| 6928 | AFP levels | GCST90278615 | 0.57 |
| 6929 | COL6A3/SPON2 ratio | GCST90314179 | 0.57 |
| 6930 | Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensive | UKBB00000673 | 0.57 |
| 6931 | Leisure/social activities - Other group activity | Social support | UKBB00000400 | 0.57 |
| 6932 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T25 | ECGU000025 | 0.57 |
| 6933 | GP6 levels | GCST90469384 | 0.57 |
| 6934 | Belief that own life is meaningful | Happiness and subjective well-being | UKBB00000090 | 0.57 |
| 6935 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320660 | 0.57 |
| 6936 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90024195 | 0.57 |
| 6937 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T325 | ECGU000325 | 0.57 |
| 6938 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T332 | ECGA000332 | 0.57 |
| 6939 | Sleep apnea | GCST90475257 | 0.57 |
| 6940 | Other disorders of fluid, electrolyte and acid-base balance | FING00001027 | 0.57 |
| 6941 | HEXIM1 levels | GCST90469447 | 0.57 |
| 6942 | GNE levels | GCST90469370 | 0.57 |
| 6943 | GKN1 levels | GCST90469353 | 0.57 |
| 6944 | ADGRE5 levels | GCST90425484 | 0.56 |
| 6945 | PTPRS levels | GCST90470387 | 0.56 |
| 6946 | IDP dMRI TBSS MO Cerebral peduncle R | GCST90003966 | 0.56 |
| 6947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T319 | ECGU000319 | 0.56 |
| 6948 | Phosphatidylglycerol (34:1) levels | GCST90025061 | 0.56 |
| 6949 | Blood cell traits latent factor 2 (red cell) | GCST90559244 | 0.56 |
| 6950 | AGT levels | GCST90468257 | 0.56 |
| 6951 | CST6/NECTIN4 ratio | GCST90314303 | 0.56 |
| 6952 | Other venous embolism and thrombosis (PheCode 452) | GCST90476007 | 0.56 |
| 6953 | IDP dMRI TBSS FA Uncinate fasciculus R | GCST90003921 | 0.56 |
| 6954 | Hereditary hemolytic anemias (PheCode 282) | GCST90475779 | 0.56 |
| 6955 | BLMH/PEAR1 ratio | GCST90313519 | 0.56 |
| 6956 | NUB1/SRPK2 ratio | GCST90315573 | 0.56 |
| 6957 | TALDO1 levels | GCST90470802 | 0.56 |
| 6958 | IGSF8/VSIR ratio | GCST90315141 | 0.56 |
| 6959 | Total Lipids in Medium LDL | GCST90498800 | 0.56 |
| 6960 | Obstructive chronic bronchitis (PheCode 496.21) | GCST90476030 | 0.56 |
| 6961 | Triacylglycerol_46:5_[M+NH4]1+ levels | GCST90060356 | 0.56 |
| 6962 | Fasting glucose | GCST90278628 | 0.56 |
| 6963 | LDL cholesterol | GCST90018741 | 0.56 |
| 6964 | PDGFA/SPARC ratio | GCST90315620 | 0.56 |
| 6965 | KIAA0040 levels | GCST90422552 | 0.56 |
| 6966 | ESAM/TNFRSF14 ratio | GCST90314720 | 0.56 |
| 6967 | CSTB levels | GCST90012006 | 0.56 |
| 6968 | CMC1 levels | GCST90468794 | 0.55 |
| 6969 | IDP dMRI TBSS L3 Sagittal stratum R | GCST90004201 | 0.55 |
| 6970 | CPXM1/LGMN ratio | GCST90314220 | 0.55 |
| 6971 | SRPK2/VASH1 ratio | GCST90315886 | 0.55 |
| 6972 | Triacylglycerol_52:2_[M+NH4]1+ levels | GCST90060511 | 0.55 |
| 6973 | Thyroid peroxidase antibody positivity with euthyroid in pregnancy | GCST90435203 | 0.55 |
| 6974 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415 | ECGU000415 | 0.55 |
| 6975 | Duration of walks | Physical activity | UKBB00000200 | 0.55 |
| 6976 | Dissociative [conversion] disorders | FING00000468 | 0.55 |
| 6977 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470 | ECGA000470 | 0.55 |
| 6978 | Valine levels | GCST90500176 | 0.55 |
| 6979 | CNTN5 levels | GCST90468807 | 0.55 |
| 6980 | EVI5 levels | GCST90469158 | 0.55 |
| 6981 | REST UKBBICA NODEamps25 0021 | GCST90385504 | 0.55 |
| 6982 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 0.55 |
| 6983 | LGALS4/PCDH17 ratio | GCST90315315 | 0.55 |
| 6984 | Triacylglycerol_50:3_[M+NH4]1+ levels | GCST90060468 | 0.55 |
| 6985 | Cerebrospinal fluid methylmalonate (MMA) levels | GCST90318243 | 0.55 |
| 6986 | Pregnancy with abortive outcome | FING00001205 | 0.55 |
| 6987 | Type 1 diabetes | GCST90018705 | 0.55 |
| 6988 | Intelligence | GCST006250 | 0.55 |
| 6989 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162 | ECGA000162 | 0.55 |
| 6990 | Types of transport used (excluding work) - Car/motor vehicle | Physical activity | UKBB00000876 | 0.55 |
| 6991 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65 | ECGA000065 | 0.55 |
| 6992 | GIT1 levels | GCST90469351 | 0.54 |
| 6993 | GUCA2A/LGALS4 ratio | GCST90314998 | 0.54 |
| 6994 | IDP dMRI TBSS FA Body of corpus callosum | GCST90003880 | 0.54 |
| 6995 | PTPRF/PTPRS ratio | GCST90315751 | 0.54 |
| 6996 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320902 | 0.54 |
| 6997 | ASGR1/GGT5 ratio | GCST90313365 | 0.54 |
| 6998 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68 | ECGA000068 | 0.54 |
| 6999 | GZMA/GZMH ratio | GCST90315008 | 0.54 |
| 7000 | Fed-up feelings | Mental health | UKBB00000242 | 0.54 |